Concord Drugs Limited announced a private placement of up to 1,256,250 convertible warrants at an issue price of INR 8.25 per warrant for proceeds of INR 10,364,062.5 on September 7, 2022. The securities will be issued at a exercise price of INR 24.75. The transaction will include participation from the promoters of the company.

The transaction has been approved by the board of directors of the company.